The University of Chicago Header Logo

Connection

Anu Neerukonda to Treatment Outcome

This is a "connection" page, showing publications Anu Neerukonda has written about Treatment Outcome.
Connection Strength

0.056
  1. Refractory Adult Primary Autoimmune Neutropenia that Responded to Alemtuzumab. Intern Med. 2016; 55(12):1667-70.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.